Search

Abstract TiO 2 film is prepared on the surface of a natural oxide layer of a monocrystalline silicon substrate via RF magnetron sputtering. HRTEM (High Resolution Transmission Electron Microscope) imaging and EDX spectroscopy are performed on the sample interface, demonstrating that the film sample has a two-layer structure. Combined with XRD, the analysis shows that the upper film is a crystalline TiO 2 film with a thickness of approximately 30 nm and that the lower film is a natural amorphous SiO 2 oxide film with a thickness of approximately 22 nm. A geometric phase analysis (GPA) and Hooke's law are used to analyse the stress and bonding state at the interfaces between the monocrystalline silicon substrate and the natural oxide layer, between rutile TiO 2 and the natural oxide layer, and between anatase TiO 2 and the natural oxide layer. It is concluded that the interface bonding state of the monocrystalline silicon/natural oxide layer is good and that the interface bonding state at the interface between rutile and the natural oxide layer is better than that between anatase and the natural oxide layer. [ABSTRACT FROM AUTHOR]

Graphical abstract Abstract A series of quinoxalinone scaffold-based acyl sulfonamides were designed as aldose reductase inhibitors and evaluated for aldose reductase (ALR2)/aldehyde reductase (ALR1) inhibition and antioxidation. Compounds 9b-g containing styryl side chains at C3-side exhibited good ALR2 inhibitory activity and selectivity. Of them, 9g demonstrated the most potent inhibitory activity with an IC 50 value of 0.100 μM, and also exhibited excellent antioxidant activity, even comparable to the typical antioxidant Trolox. Compounds 9 had higher lipid-water partition coefficients relative to the carboxylic acid compounds 8 , indicating that they may have better lipophilicity and membrane permeability. Structure-activity relationship (SAR) studies found that acyl trifluoromethanesulfonamide group at N1 and the C3-dihydroxystyryl side chain were the key structure for improving the aldose reductase inhibitory activity and antioxidant activity. [ABSTRACT FROM AUTHOR]

Diabetic nephropathy (DN) is resulted from activations of polyol pathway and oxidative stress by abnormal metabolism of glucose, and no specific medication is available. We designed a novel class of benzoxazolone derivatives, and a number of individuals were found to have significant antioxidant activity and inhibition of aldose reductase of the key enzyme in the polyol pathway. The outstanding compound (E)-2-(7-(4-hydroxy-3-methoxystyryl)-2-oxobenzo[d]oxazol-3(2H)-yl)acetic acid was identified to reduce urinary proteins in diabetic mice suggesting an alleviation in the diabetic nephropathy, and this was confirmed by kidney hematoxylin-eosin staining. Further investigations showed blood glucose normalization, declined in the polyol pathway and lipid peroxides, and raised glutathione and superoxide dismutase activity. Thus, we suggest a therapeutic function of the compound for DN which could be attributed to the combination of hypoglycemic, aldose reductase inhibition and antioxidant. [Display omitted] • A novel class of benzoxazolone derivatives had significant activities in antioxidant and inhibition of aldose reductase. • Most potent one of them showed the activities in diabetic mice and also in blood glucose normalization. • An alleviation in diabetic nephropathy was confirmed by urinary proteins reduction and kidney hematoxylin-eosin staining. [ABSTRACT FROM AUTHOR]

Dihydrobenzoxazinone derivatives revealed potent activities of aldose reductase inhibition and antioxidant against diabetic complications. Dihydrobenzoxazinone based design and synthesis produced two series of compounds as aldose reductase (ALR2) inhibitor candidates. In particular, phenolic residues were embodied into the compounds for the combination of strengthening the inhibitory acitvity and antioxidant ability to retard the progression of diabetic complications. Most of the derivatives with styryl side chains exhibited excellent activities on selective ALR2 inhibition with IC 50 values ranging from 0.082 to 0.308 μM, and {8-[2-(4-hydroxy-phenyl)-vinyl]-2-oxo-2,3-dihydro-benzo[1,4]oxazin-4-yl}-acetic acid (3a) was the most potent. More significantly, most of dihydrobenzoxazinone compounds revealed not only good inhibitory effect on ALR2, but also showed powerful antioxidant activity. Notably, phenolic compound 3a was even comparable to the well-known antioxidant Trolox, confirming that the C8 p-hydroxystyryl substitution was key structure of lowering oxidative stress. Therefore, these results provided an achievement of multifunctional ALR2 inhibitors possessing capacities for both ALR2 inhibition and as antioxidants. [ABSTRACT FROM AUTHOR]